Difference between revisions of "Part:BBa K2920727"

 
(50 intermediate revisions by the same user not shown)
Line 3: Line 3:
 
<partinfo>BBa_K2920727 short</partinfo>
 
<partinfo>BBa_K2920727 short</partinfo>
  
BBa_K2920727 (jj01)antimicrobial peptide is our target gene from 2019 Tunghai_TAPG iGEM team, we can prove the antimicrobial function of the peptide after we translated our peptide from the amino acid to the DNA code, so we mass production our specific peptide by genetic engineering method and made it into the product.
+
BBa_K2920727 (JJ01)antimicrobial peptide is our target gene from 2019 Tunghai_TAPG iGEM team, we can prove the antimicrobial function of the peptide after we translated our peptide from the amino acid to the DNA code, so we mass production our specific peptide by genetic engineering method and made it into the product.
 
AMPs is a currently a potential defense against multidrug-resistant (MDR) pathogens which is naturally occurring molecular as an alternative to antibiotic. This kind of molecular have broad activity to directly kill many organisms for instance bacteria, yeast, and fungi etc. Peptide is composed of different length and different arrangement of amino acid. Unlike antibiotic, AMPs have diverse mechanism against bacteria which make it hard to develop a complete resistance. Generally, bacteria membrane is composed of liquid bilayer structure.
 
AMPs is a currently a potential defense against multidrug-resistant (MDR) pathogens which is naturally occurring molecular as an alternative to antibiotic. This kind of molecular have broad activity to directly kill many organisms for instance bacteria, yeast, and fungi etc. Peptide is composed of different length and different arrangement of amino acid. Unlike antibiotic, AMPs have diverse mechanism against bacteria which make it hard to develop a complete resistance. Generally, bacteria membrane is composed of liquid bilayer structure.
 
TungHai iGEM aim to ameliorate the hospital environment by air purifier(the antimicrobial peptide liquid), we observed that people are suffering HAI (Hospital Acquired Infection) these days. HAI (Hospital acquired infection) literally it is an infection get caught during hospitalization. To be more academically, we call it nosocomial in medical. Most of the time, HAI is often cause by the bacteria since recently the increase of the abuse of antibiotic in the hospital.
 
TungHai iGEM aim to ameliorate the hospital environment by air purifier(the antimicrobial peptide liquid), we observed that people are suffering HAI (Hospital Acquired Infection) these days. HAI (Hospital acquired infection) literally it is an infection get caught during hospitalization. To be more academically, we call it nosocomial in medical. Most of the time, HAI is often cause by the bacteria since recently the increase of the abuse of antibiotic in the hospital.
 
-----------------------------------------------------------------
 
-----------------------------------------------------------------
 
<data>
 
<data>
JJ01  
+
<font size="4"><strong>JJ01 </strong></font size>
JJ01(Fig.1) is a antimicrobial peptide which is originally modify from MAP0403. As previous study indicated that although MAP0403 has antimicrobial potency, it has side effect- hemolytic which is not suitable for potential.According to the research, the high amphipathic alpha helical character may interact with membrane which include the properties of detergent and its analogies between both of its interface. In order to solve the side effect, JJ01 changed the amphipathic structure arrangement of MAP0403 to interfere the detergent-like structure as the first and foremost strategy.After identify the antimicrobial activity, JJ01 is found to inhibited E coli, S. aureus and P. aeruginosa at 5 μM, 5 μM and 10 μM, respectively. The minimal inhibition concentration (MIC90) of P. aeruginosa increased twice, but E coli and S. aureus still maintain at 5 μM. Fortunately, jj01 was proved to significant decrease the hemolytic activity by break down the amphipathic structure.In conclusion, JJ01 is an effective antimicrobiaol peptide which has potential to replace antibiotic.
+
<br>JJ01(<strong>Fig.1</strong>) is a antimicrobial peptide which is originally modify from MAP0403. As previous study indicated that although MAP0403 has antimicrobial potency, it has side effect- hemolytic which is not suitable for potential usage.According to the research, high amphipathic alpha helical character may interact with membrane which include the properties of detergent and its analogies between both of its interface. In order to solve the side effect, JJ01 changed the amphipathic structure arrangement of MAP0403 to interfere the detergent-like structure as the most crucial strategy.After identify the antimicrobial activity, JJ01 is found to inhibited <I>E coli</I>, <I>S. aureus</I> and <I>P. aeruginosa</I> effectively. Fortunately, JJ01 alos proved to significant decrease the hemolytic activity by break down the amphipathic structure.In conclusion, JJ01 is an effective antimicrobiaol peptide which has potential to replace antibiotic.<br>
 
[[File:T--Tunghai TAPG--jj01 helical wheel.png]]
 
[[File:T--Tunghai TAPG--jj01 helical wheel.png]]
Fig.1. Helical wheel projection of JJ01<p>
+
 
 +
<strong>Figure.1.</strong> Helical wheel projection of JJ01
 +
 
 
[[File:T--Tunghai TAPG--jj01 crude rphplc.png]]
 
[[File:T--Tunghai TAPG--jj01 crude rphplc.png]]
Fig.2. RP-HPLC chromatogram of the crude peptide JJ01 <br>
+
 
 +
<strong>Figure.2.</strong> RP-HPLC chromatogram of the crude peptide JJ01  
 +
 
 
[[File:T--Tunghai TAPG--jj01 pure.png]]
 
[[File:T--Tunghai TAPG--jj01 pure.png]]
Fig.3. RP-HPLC chromatogram of the pure peptide JJ01 <br>
 
[[File:T--Tunghai TAPG--jj01 maldi.png]]
 
Fig.4. MALDI-TOF-MS spectrum of pure JJ01 <br>
 
  
 +
<strong>Figure.3.</strong> RP-HPLC chromatogram of the pure peptide JJ01
  
geneic engineerng method
+
[[File:T--Tunghai TAPG--jj01 maldi.png]]
  
3.4. Procedure
+
<strong>Figure.4.</strong> MALDI-TOF-MS spectrum of pure JJ01
 
+
 
1. Identify target gene
+
-----------------------------------------------------
 +
<font size="4"><strong>Geneic Engineerng Procedure</strong></font>
 +
<br>1. Identify target gene <br>
 
    
 
    
2. Design primer
+
<br>2. Design primer<br>
 
      
 
      
3. Polymerase chain reaction  
+
<br>3. Polymerase chain reaction <br>
 
    
 
    
4. DNA purification  
+
<br>4. DNA purification <br>
 
    
 
    
5. Extract target DNA from plastid   
+
<br>5. Extract target DNA from plastid<br>  
 
    
 
    
6. First transformation  
+
<br>6. First transformation <br>
 
    
 
    
7. Confirm fragment size of plastid   
+
<br>7. Confirm fragment size of plastid<br>  
 
    
 
    
8. Sequencing  
+
<br>8. Sequencing <br>
 
    
 
    
9. Second transformation  
+
<br>9. Second transformation <br>
 
    
 
    
10. Protein expression
+
<br>10. Protein expression<br>
 
      
 
      
11. Identify purification conditions  
+
<br>11. Identify purification conditions <br>
 
    
 
    
12. Protein expression and purification  
+
<br>12. Protein expression and purification <br>
 
    
 
    
13. Antimicrobial activity analysis
+
<br>13. Antimicrobial activity analysis<br>
 
-------------------------------------------------------------
 
-------------------------------------------------------------
<Antibacterial data>
+
<font size="4"><strong>Antibacterial data </strong></font size>
Figure 1. antimicrobial activiy of JJ01 indicated that JJ-01 inhibited E coli, S. aureus and P. aeruginosa respectively at the range of 0 μM to 10μM . The results was demonstrated  that MIC90 of E coli, S. aureus and P. aeruginosa was 5 μM, 5 μM and 10 μM respectively.
+
<br><strong>Figure 1.</strong> Antimicrobial activiy of JJ01 indicated that JJ-01 inhibited <I>E.coli</I>, <I>S.aureus</I> and <I>P. aeruginosa</I> respectively at the range of 0 μM to 10μM . The results was demonstrated  that MIC<SUB>90</SUB> of <I>E. coli</I>, <I>S. aureus</I> and <I>P. aeruginosa</I> was 5 μM, 5 μM and 10 μM respectively. MIC<SUB>90</SUB> were defined as the lowest concentration of the peptide at which 90  of the isolates were inhibited.<br>
MIC90 were defined as the lowest concentration of the peptide at which 90  of the isolates were inhibited.
+
 
[[File:T--Tunghai TAPG--jj01 mic90.png]]
 
[[File:T--Tunghai TAPG--jj01 mic90.png]]
Figure 1. antimicrobial activiy of JJ01
+
<br><strong>Figure 1.</strong> Antimicrobial activiy of JJ01<br>
  
  
Line 60: Line 63:
  
 
-------------------------------------------------------------
 
-------------------------------------------------------------
-------------------------------------------------------------
+
<font size="4"><strong>Usage</strong></font size>
<Usage>
+
  
TungHai iGEM aim to ameliorate the hospital environment by air purifier(the antimicrobial peptide liquid), we observed that people are suffering HAI (Hospital Acquired Infection) these days. HAI (Hospital acquired infection) literally it is an infection get caught during hospitalization. To be more academically, we call it nosocomial in medical. Most of the time, HAI is often cause by the bacteria since recently the increase of the abuse of antibiotic in the hospital.
+
<br>TungHai iGEM aim to ameliorate the hospital environment by air purifier(the antimicrobial peptide liquid), we observed that people are suffering HAI (Hospital Acquired Infection) these days. HAI (Hospital acquired infection) literally it is an infection get caught during hospitalization. To be more academically, we call it nosocomial in medical. Most of the time, HAI is often cause by the bacteria since recently the increase of the abuse of antibiotic in the hospital.<br>
The combination of JJ01 and other biobricks .
+
[[File:T--Tunghai TAPG--BIOBRICK.png]]
+
  
<Biology>
+
<br>The combination of JJ01 and other biobricks.<br>
 +
https://2019.igem.org/wiki/images/e/e4/T--Tunghai_TAPG--_BIO.jpg
 +
-------------------------------------------------------------
 +
<font size="4"><strong>Biology</strong></font size>
  
<Characterization>
+
-------------------------------------------------------------
Characterization of Fluorescence intensity
+
<font size="4"><strong>Characterization of Fluorescence Intensity</strong></font size>
 
+
<br>The TAPG tunghai team 2019 are using our peptide JJ01’s back end combined with BBa_K1911005, and adding IPTG induction for expression, to ensure the accuracy of our protein expression, and using fluorescent protein as the identification, to get the yield of our protein. Among of these, we have four different cells in total (normal BL21, BL21 with fluorescent protein, BL21 adding IPTG, BL21 with fluorescent protein adding IPTG), we are using these three ways to ensure the accuracy.<br>
The TAPG tunghai team 2019 are using our peptide jj01’s back end combined with BBa_K1911005, and adding IPTG induction for expression, to ensure the accuracy of our protein expression, and using fluorescent protein as the identification, to get the yield of our protein. Among of these, we have four different cells in total (normal BL21, BL21 with fluorescent protein, BL21 adding IPTG, BL21 with fluorescent protein adding IPTG), we are using these three ways to ensure the accuracy.
+
  
In figure 1., the x-axis refers to time, the y-axis refers to OD value. We tested the OD600 of four cells, continually to 24 hours, observed the growth curve. Apparently, there is no obvious gap of these four cells.
+
In <strong>Figure 1.</strong>, the x-axis refers to time, the y-axis refers to OD value. We tested the OD600 of four cells, continually to 24 hours, observed the growth curve. Apparently, there is no obvious gap of these four cells.
  
In figure 2., the x-axis refers to time, the y-axis refers to Fluorescence intensity. We tested four cells’ Fluorescence intensity individually (Ex/Em=488/518nm), we could see that, the curves of two cells without EGFP are not overlapping, and at the very bottom of the chart. As for the cell with IEGFG but without IPTG induction, the curve stay remain and send out tiny fluorescent. When IPTG are adding in the cell with fluorescent, we could see that the curve has an obvious change, we add 1 mm IPTG, when OD are grown to 0.8, we can know that the curve has a dramatically growth.
+
In <strong>Figure 2.</strong>, the x-axis refers to time, the y-axis refers to Fluorescence intensity. We tested four cells’ Fluorescence intensity individually (Ex/Em=488/518nm), we could see that, the curves of two cells without EGFP are not overlapping, and at the very bottom of the chart. As for the cell with IEGFG but without IPTG induction, the curve stay remain and send out tiny fluorescent. When IPTG are adding in the cell with fluorescent, we could see that the curve has an obvious change, we add 1 mm IPTG, when OD are grown to 0.8, we can know that the curve has a dramatically growth.
  
In figure 3., the x-axis refers to time, the y-axis refers to Fluorescence intensity. We divided figure 2. by figure 1., get the Fluorescence intensity of four different kind of cells per unit; then we are able to measure our productions correctly by knowing Fluorescence intensity from each cells. Because the quantity of Fluorescence protein was proportional to the target gene that is going to be expressed. In order to know how many Fluorescence intensity each bacteria produces, we have to divide the numbers of bacteria by total Fluorescence intensity, what we get is the quantity of the Fluorescence intensity per bacteria produces.
+
In <strong>Figure 3.</strong>, the x-axis refers to time, the y-axis refers to Fluorescence intensity. We divided <strong>Figure 2.</strong> by <strong>Figure 1.</strong>, get the Fluorescence intensity of four different kind of cells per unit; then we are able to measure our productions correctly by knowing Fluorescence intensity from each cells. Because the quantity of Fluorescence protein was proportional to the target gene that is going to be expressed. In order to know how many Fluorescence intensity each bacteria produces, we have to divide the numbers of bacteria by total Fluorescence intensity, what we get is the quantity of the Fluorescence intensity per bacteria produces.<br>
 
[[File:T--Tunghai TAPG--od600.png]]
 
[[File:T--Tunghai TAPG--od600.png]]
Figure.1 OD600
+
<br><strong>Figure.1</strong> OD600<br>
 
[[File:T--Tunghai TAPG--gfp1.png]]
 
[[File:T--Tunghai TAPG--gfp1.png]]
Figure.2 Ex/Em=488/518 nm
+
<br><strong>Figure.2</strong> Ex/Em=488/518 nm<br>
 
[[File:T--Tunghai TAPG--gfp2.png]]
 
[[File:T--Tunghai TAPG--gfp2.png]]
Figure.3 Ex/Em=488/518 nm normalized with OD600
+
<br><strong>Figure.3</strong> Ex/Em=488/518 nm normalized with OD600<br>
 
------------------------------------------------------
 
------------------------------------------------------
  
the condition of the characterization
+
<font size="4"><strong>The Condition of the Characterization</strong></font size>
  
Day 1 ↓ culture E. coli BL21(DE3) carrying vector only or T7-RBS-EGFP in LB + Kan (50 ug/ml) O/N at 37°C
+
Day 1 ↓ culture <I>E. coli</I> BL21(DE3) carrying vector only or T7-RBS-EGFP in LB + Kan (50 ug/ml) O/N at 37°C
 
 
 
Day 2 ↓ measure OD600
 
Day 2 ↓ measure OD600

Latest revision as of 13:07, 20 October 2019


Effective AMP (Antimicrobial Peptide)

BBa_K2920727 (JJ01)antimicrobial peptide is our target gene from 2019 Tunghai_TAPG iGEM team, we can prove the antimicrobial function of the peptide after we translated our peptide from the amino acid to the DNA code, so we mass production our specific peptide by genetic engineering method and made it into the product. AMPs is a currently a potential defense against multidrug-resistant (MDR) pathogens which is naturally occurring molecular as an alternative to antibiotic. This kind of molecular have broad activity to directly kill many organisms for instance bacteria, yeast, and fungi etc. Peptide is composed of different length and different arrangement of amino acid. Unlike antibiotic, AMPs have diverse mechanism against bacteria which make it hard to develop a complete resistance. Generally, bacteria membrane is composed of liquid bilayer structure. TungHai iGEM aim to ameliorate the hospital environment by air purifier(the antimicrobial peptide liquid), we observed that people are suffering HAI (Hospital Acquired Infection) these days. HAI (Hospital acquired infection) literally it is an infection get caught during hospitalization. To be more academically, we call it nosocomial in medical. Most of the time, HAI is often cause by the bacteria since recently the increase of the abuse of antibiotic in the hospital.


JJ01
JJ01(Fig.1) is a antimicrobial peptide which is originally modify from MAP0403. As previous study indicated that although MAP0403 has antimicrobial potency, it has side effect- hemolytic which is not suitable for potential usage.According to the research, high amphipathic alpha helical character may interact with membrane which include the properties of detergent and its analogies between both of its interface. In order to solve the side effect, JJ01 changed the amphipathic structure arrangement of MAP0403 to interfere the detergent-like structure as the most crucial strategy.After identify the antimicrobial activity, JJ01 is found to inhibited E coli, S. aureus and P. aeruginosa effectively. Fortunately, JJ01 alos proved to significant decrease the hemolytic activity by break down the amphipathic structure.In conclusion, JJ01 is an effective antimicrobiaol peptide which has potential to replace antibiotic.
T--Tunghai TAPG--jj01 helical wheel.png

Figure.1. Helical wheel projection of JJ01

T--Tunghai TAPG--jj01 crude rphplc.png

Figure.2. RP-HPLC chromatogram of the crude peptide JJ01

T--Tunghai TAPG--jj01 pure.png

Figure.3. RP-HPLC chromatogram of the pure peptide JJ01

T--Tunghai TAPG--jj01 maldi.png

Figure.4. MALDI-TOF-MS spectrum of pure JJ01


Geneic Engineerng Procedure
1. Identify target gene


2. Design primer


3. Polymerase chain reaction


4. DNA purification


5. Extract target DNA from plastid


6. First transformation


7. Confirm fragment size of plastid


8. Sequencing


9. Second transformation


10. Protein expression


11. Identify purification conditions


12. Protein expression and purification


13. Antimicrobial activity analysis


Antibacterial data
Figure 1. Antimicrobial activiy of JJ01 indicated that JJ-01 inhibited E.coli, S.aureus and P. aeruginosa respectively at the range of 0 μM to 10μM . The results was demonstrated that MIC90 of E. coli, S. aureus and P. aeruginosa was 5 μM, 5 μM and 10 μM respectively. MIC90 were defined as the lowest concentration of the peptide at which 90 of the isolates were inhibited.
T--Tunghai TAPG--jj01 mic90.png
Figure 1. Antimicrobial activiy of JJ01




Usage


TungHai iGEM aim to ameliorate the hospital environment by air purifier(the antimicrobial peptide liquid), we observed that people are suffering HAI (Hospital Acquired Infection) these days. HAI (Hospital acquired infection) literally it is an infection get caught during hospitalization. To be more academically, we call it nosocomial in medical. Most of the time, HAI is often cause by the bacteria since recently the increase of the abuse of antibiotic in the hospital.


The combination of JJ01 and other biobricks.
T--Tunghai_TAPG--_BIO.jpg


Biology


Characterization of Fluorescence Intensity
The TAPG tunghai team 2019 are using our peptide JJ01’s back end combined with BBa_K1911005, and adding IPTG induction for expression, to ensure the accuracy of our protein expression, and using fluorescent protein as the identification, to get the yield of our protein. Among of these, we have four different cells in total (normal BL21, BL21 with fluorescent protein, BL21 adding IPTG, BL21 with fluorescent protein adding IPTG), we are using these three ways to ensure the accuracy.

In Figure 1., the x-axis refers to time, the y-axis refers to OD value. We tested the OD600 of four cells, continually to 24 hours, observed the growth curve. Apparently, there is no obvious gap of these four cells.

In Figure 2., the x-axis refers to time, the y-axis refers to Fluorescence intensity. We tested four cells’ Fluorescence intensity individually (Ex/Em=488/518nm), we could see that, the curves of two cells without EGFP are not overlapping, and at the very bottom of the chart. As for the cell with IEGFG but without IPTG induction, the curve stay remain and send out tiny fluorescent. When IPTG are adding in the cell with fluorescent, we could see that the curve has an obvious change, we add 1 mm IPTG, when OD are grown to 0.8, we can know that the curve has a dramatically growth.

In Figure 3., the x-axis refers to time, the y-axis refers to Fluorescence intensity. We divided Figure 2. by Figure 1., get the Fluorescence intensity of four different kind of cells per unit; then we are able to measure our productions correctly by knowing Fluorescence intensity from each cells. Because the quantity of Fluorescence protein was proportional to the target gene that is going to be expressed. In order to know how many Fluorescence intensity each bacteria produces, we have to divide the numbers of bacteria by total Fluorescence intensity, what we get is the quantity of the Fluorescence intensity per bacteria produces.
T--Tunghai TAPG--od600.png
Figure.1 OD600
T--Tunghai TAPG--gfp1.png
Figure.2 Ex/Em=488/518 nm
T--Tunghai TAPG--gfp2.png
Figure.3 Ex/Em=488/518 nm normalized with OD600


The Condition of the Characterization

Day 1 ↓ culture E. coli BL21(DE3) carrying vector only or T7-RBS-EGFP in LB + Kan (50 ug/ml) O/N at 37°C

Day 2 ↓ measure OD600

↓ dilute to OD600 around 0.1

↓ shake at 200 rpm, 37°C until OD600 around 0.8

↓ add 1mM IPTG for protein induction

↓ measure OD600 and Ex/Em=488/518 nm every 30min for 24hr

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]